Skip to main content
Top
Published in: Cancer Cell International 1/2010

Open Access 01-12-2010 | Primary research

MicroRNA-26a-mediated regulation of interleukin-2 expression in transformed avian lymphocyte lines

Authors: Hongtao Xu, Yongxiu Yao, Lorraine P Smith, Venugopal Nair

Published in: Cancer Cell International | Issue 1/2010

Login to get access

Abstract

Background

Micro(mi)RNAs are a class of small non-coding RNAs that play critical roles in the induction of various cancers, including lymphomas induced by oncogenic viruses. While some of the miRNAs are oncogenic, miRNAs such as miR-26a are consistently downregulated in a number of cancers, demonstrating their potential tumor suppressor functions. Global miRNA expression profiles of a number of virus-transformed avian lymphoma cell lines have shown downregulation of gga-miR-26a expression, irrespective of molecular mechanisms of transformation or the viral aetiology. The neoplastic transformation of lymphocytes by many viruses accompanies high levels of proliferative responses, mostly mediated through cytokines such as IL-2. Chicken IL-2 can modulate T-cell proliferation and cytotoxicity in vitro and in vivo and dysregulation of IL-2 expression is observed in diseases such as leukaemia.

Results

The expression levels of gga-miR-26a in chicken lymphoma cells transformed by 3 distinct avian oncogenic viruses, viz Marek's disease virus (MDV), avian leukosis virus (ALV) and Reticuloendotheliosis virus (REV) were consistently downregulated compared to the levels in the normal lymphocytes. This downregulation of miR-26a regardless of the viral etiology and molecular mechanisms of transformation was consistent with the tumor suppressor role of this miRNA. Notwithstanding this well-established role in cancer, we demonstrate the additional role of this miRNA in directly targeting chicken IL-2 through reporter and biochemical assays. The downregulation of miR-26a can relieve the suppressive effect of this miRNA on IL-2 expression.

Conclusions

We show that miR-26a is globally downregulated in a number of avian lymphoma cells irrespective of the mechanisms of transformation, reiterating the highly conserved tumor suppressor function of this miRNA. However, with the potential for directly targeting chicken IL-2, the downregulation of miR-26a in these tumor cells could relieve the inhibitory effect on IL-2 expression assisting in the proliferative features of the transformed lymphocyte lines.
Appendix
Available only for authorised users
Literature
2.
go back to reference Calnek BW: Marek's disease: a model for herpesvirus oncology. CRC Crit Rev Microbiol. 1986, 12: 293-320. 10.3109/10408418509104432.CrossRef Calnek BW: Marek's disease: a model for herpesvirus oncology. CRC Crit Rev Microbiol. 1986, 12: 293-320. 10.3109/10408418509104432.CrossRef
3.
go back to reference Yao Y, Zhao Y, Smith LP, Lawrie CH, Saunders NJ, Watson M, Nair V: Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. J Gen Virol. 2009, 90: 1551-9. 10.1099/vir.0.009902-0.CrossRefPubMed Yao Y, Zhao Y, Smith LP, Lawrie CH, Saunders NJ, Watson M, Nair V: Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. J Gen Virol. 2009, 90: 1551-9. 10.1099/vir.0.009902-0.CrossRefPubMed
4.
go back to reference Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT: Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008, 40: 43-50. 10.1038/ng.2007.30.PubMedCentralCrossRefPubMed Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT: Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008, 40: 43-50. 10.1038/ng.2007.30.PubMedCentralCrossRefPubMed
5.
go back to reference Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009, 137: 1005-17. 10.1016/j.cell.2009.04.021.PubMedCentralCrossRefPubMed Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009, 137: 1005-17. 10.1016/j.cell.2009.04.021.PubMedCentralCrossRefPubMed
6.
go back to reference Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A: Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007, 26: 7590-5. 10.1038/sj.onc.1210564.CrossRefPubMed Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A: Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007, 26: 7590-5. 10.1038/sj.onc.1210564.CrossRefPubMed
7.
go back to reference Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007, 26: 745-52. 10.1016/j.molcel.2007.05.010.PubMedCentralCrossRefPubMed Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007, 26: 745-52. 10.1016/j.molcel.2007.05.010.PubMedCentralCrossRefPubMed
8.
go back to reference Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009, 23: 1327-37. 10.1101/gad.1777409.PubMedCentralCrossRefPubMed Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009, 23: 1327-37. 10.1101/gad.1777409.PubMedCentralCrossRefPubMed
9.
go back to reference Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Moller P, Stilgenbauer S, Pollack JR, Wirth T: MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008, 112: 4202-12. 10.1182/blood-2008-03-147645.CrossRefPubMed Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Moller P, Stilgenbauer S, Pollack JR, Wirth T: MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008, 112: 4202-12. 10.1182/blood-2008-03-147645.CrossRefPubMed
10.
go back to reference Gesbert F, Delespine-Carmagnat M, Bertoglio J: Recent advances in the understanding of interleukin-2 signal transduction. J Clin Immunol. 1998, 18: 307-20. 10.1023/A:1023223614407.CrossRefPubMed Gesbert F, Delespine-Carmagnat M, Bertoglio J: Recent advances in the understanding of interleukin-2 signal transduction. J Clin Immunol. 1998, 18: 307-20. 10.1023/A:1023223614407.CrossRefPubMed
11.
go back to reference Kaiser P, Underwood G, Davison F: Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J Virol. 2003, 77: 762-8. 10.1128/JVI.77.1.762-768.2003.PubMedCentralCrossRefPubMed Kaiser P, Underwood G, Davison F: Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J Virol. 2003, 77: 762-8. 10.1128/JVI.77.1.762-768.2003.PubMedCentralCrossRefPubMed
12.
go back to reference Stepaniak JA, Shuster JE, Hu W, Sundick RS: Production and in vitro characterization of recombinant chicken interleukin-2. J Interferon Cytokine Res. 1999, 19: 515-26. 10.1089/107999099313965.CrossRefPubMed Stepaniak JA, Shuster JE, Hu W, Sundick RS: Production and in vitro characterization of recombinant chicken interleukin-2. J Interferon Cytokine Res. 1999, 19: 515-26. 10.1089/107999099313965.CrossRefPubMed
13.
go back to reference Rothenberg EV, Ward SB: A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc Natl Acad Sci USA. 1996, 93: 9358-65. 10.1073/pnas.93.18.9358.PubMedCentralCrossRefPubMed Rothenberg EV, Ward SB: A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc Natl Acad Sci USA. 1996, 93: 9358-65. 10.1073/pnas.93.18.9358.PubMedCentralCrossRefPubMed
14.
go back to reference Wang J, Lee S, Teh CE, Bunting K, Ma L, Shannon MF: The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells. Int Immunol. 2009, 21: 227-35. 10.1093/intimm/dxn143.CrossRefPubMed Wang J, Lee S, Teh CE, Bunting K, Ma L, Shannon MF: The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells. Int Immunol. 2009, 21: 227-35. 10.1093/intimm/dxn143.CrossRefPubMed
15.
go back to reference Petrocca F, Lieberman J: Micromanagers of immune cell fate and function. Adv Immunol. 2009, 102: 227-44. full_text.CrossRefPubMed Petrocca F, Lieberman J: Micromanagers of immune cell fate and function. Adv Immunol. 2009, 102: 227-44. full_text.CrossRefPubMed
16.
go back to reference Xiao C, Rajewsky K: MicroRNA control in the immune system: basic principles. Cell. 2009, 136: 26-36. 10.1016/j.cell.2008.12.027.CrossRefPubMed Xiao C, Rajewsky K: MicroRNA control in the immune system: basic principles. Cell. 2009, 136: 26-36. 10.1016/j.cell.2008.12.027.CrossRefPubMed
18.
go back to reference Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V, Macino G: An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and AICD in T lymphocytes. Blood. 2010, 115: 265-73. 10.1182/blood-2009-06-225987.CrossRefPubMed Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V, Macino G: An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and AICD in T lymphocytes. Blood. 2010, 115: 265-73. 10.1182/blood-2009-06-225987.CrossRefPubMed
19.
go back to reference Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J, Garcia-Foncillas J: microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res. 2009, 15: 2281-90. 10.1158/1078-0432.CCR-08-1818.CrossRefPubMed Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J, Garcia-Foncillas J: microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res. 2009, 15: 2281-90. 10.1158/1078-0432.CCR-08-1818.CrossRefPubMed
20.
go back to reference Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M: Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol. 2009, 34: 1069-75.PubMed Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M: Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol. 2009, 34: 1069-75.PubMed
21.
go back to reference Sun R, Fu X, Li Y, Xie Y, Mao Y: Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours. BMC Genomics. 2009, 10: 93-10.1186/1471-2164-10-93.PubMedCentralCrossRefPubMed Sun R, Fu X, Li Y, Xie Y, Mao Y: Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours. BMC Genomics. 2009, 10: 93-10.1186/1471-2164-10-93.PubMedCentralCrossRefPubMed
22.
go back to reference Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ, Schlecht NF: Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cellcarcinoma. Am J Pathol. 2009, 174: 736-45. 10.2353/ajpath.2009.080731.PubMedCentralCrossRefPubMed Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ, Schlecht NF: Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cellcarcinoma. Am J Pathol. 2009, 174: 736-45. 10.2353/ajpath.2009.080731.PubMedCentralCrossRefPubMed
23.
go back to reference Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S: Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology. 2009, 49: 1098-112. 10.1002/hep.22749.CrossRefPubMed Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S: Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology. 2009, 49: 1098-112. 10.1002/hep.22749.CrossRefPubMed
24.
go back to reference Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, Xu J, Cheng JQ, Lin JY, Ma X: Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 2009, 25: 13-20. 10.1007/s00381-008-0701-x.CrossRefPubMed Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, Xu J, Cheng JQ, Lin JY, Ma X: Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 2009, 25: 13-20. 10.1007/s00381-008-0701-x.CrossRefPubMed
25.
go back to reference Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M, Hu CX: Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol. 2008, 23: 87-94. 10.1111/j.1440-1746.2008.05488.x.CrossRefPubMed Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M, Hu CX: Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol. 2008, 23: 87-94. 10.1111/j.1440-1746.2008.05488.x.CrossRefPubMed
26.
go back to reference Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML: Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res. 2008, 23: 287-95. 10.1359/jbmr.071011.CrossRefPubMed Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML: Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res. 2008, 23: 287-95. 10.1359/jbmr.071011.CrossRefPubMed
27.
go back to reference Rossi JJ: New hope for a microRNA therapy for liver cancer. Cell. 2009, 137: 990-2. 10.1016/j.cell.2009.05.038.CrossRefPubMed Rossi JJ: New hope for a microRNA therapy for liver cancer. Cell. 2009, 137: 990-2. 10.1016/j.cell.2009.05.038.CrossRefPubMed
28.
go back to reference Rochman Y, Spolski R, Leonard WJ: New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol. 2009, 9: 480-90. 10.1038/nri2580.PubMedCentralCrossRefPubMed Rochman Y, Spolski R, Leonard WJ: New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol. 2009, 9: 480-90. 10.1038/nri2580.PubMedCentralCrossRefPubMed
29.
go back to reference Levy AM, Izumiya Y, Brunovskis P, Xia L, Parcells MS, Reddy SM, Lee L, Chen HW, Kung HJ: Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells. J Virol. 2003, 77: 12841-51. 10.1128/JVI.77.23.12841-12851.2003.PubMedCentralCrossRefPubMed Levy AM, Izumiya Y, Brunovskis P, Xia L, Parcells MS, Reddy SM, Lee L, Chen HW, Kung HJ: Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells. J Virol. 2003, 77: 12841-51. 10.1128/JVI.77.23.12841-12851.2003.PubMedCentralCrossRefPubMed
30.
go back to reference Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A: Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet. 2006, 38: 1060-5. 10.1038/ng1855.PubMedCentralCrossRefPubMed Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A: Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet. 2006, 38: 1060-5. 10.1038/ng1855.PubMedCentralCrossRefPubMed
31.
go back to reference Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY: MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 2007, 67: 8433-8. 10.1158/0008-5472.CAN-07-1585.CrossRefPubMed Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY: MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 2007, 67: 8433-8. 10.1158/0008-5472.CAN-07-1585.CrossRefPubMed
32.
go back to reference Nair V, Kung HJ: Marek's disease virus oncogenicity: Molecular mechanisms. Marek's disease, an evolving problem. Edited by: Davison F, Nair V. 2004, Elsevier Academic Press, Oxford, 32-48. full_text.CrossRef Nair V, Kung HJ: Marek's disease virus oncogenicity: Molecular mechanisms. Marek's disease, an evolving problem. Edited by: Davison F, Nair V. 2004, Elsevier Academic Press, Oxford, 32-48. full_text.CrossRef
33.
go back to reference Lawrie CH, Saunders NJ, Soneji S, Palazzo S, Dunlop HM, Cooper CD, Brown PJ, Troussard X, Mossafa H, Enver T, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS: MicroRNA expression in lymphocyte development and malignancy. Leukemia. 2008, 22: 1440-6. 10.1038/sj.leu.2405083.CrossRefPubMed Lawrie CH, Saunders NJ, Soneji S, Palazzo S, Dunlop HM, Cooper CD, Brown PJ, Troussard X, Mossafa H, Enver T, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS: MicroRNA expression in lymphocyte development and malignancy. Leukemia. 2008, 22: 1440-6. 10.1038/sj.leu.2405083.CrossRefPubMed
34.
go back to reference Yao Y, Zhao Y, Smith LP, Watson M, Nair V: Novel microRNAs (miRNAs) encoded by herpesvirus of Turkeys: evidence of miRNA evolution by duplication. J Virol. 2009, 83: 6969-73. 10.1128/JVI.00322-09.PubMedCentralCrossRefPubMed Yao Y, Zhao Y, Smith LP, Watson M, Nair V: Novel microRNAs (miRNAs) encoded by herpesvirus of Turkeys: evidence of miRNA evolution by duplication. J Virol. 2009, 83: 6969-73. 10.1128/JVI.00322-09.PubMedCentralCrossRefPubMed
35.
go back to reference Himly M, Foster DN, Bottoli I, Iacovoni JS, Vogt PK: The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology. 1998, 248: 295-304. 10.1006/viro.1998.9290.CrossRefPubMed Himly M, Foster DN, Bottoli I, Iacovoni JS, Vogt PK: The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology. 1998, 248: 295-304. 10.1006/viro.1998.9290.CrossRefPubMed
Metadata
Title
MicroRNA-26a-mediated regulation of interleukin-2 expression in transformed avian lymphocyte lines
Authors
Hongtao Xu
Yongxiu Yao
Lorraine P Smith
Venugopal Nair
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2010
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-10-15

Other articles of this Issue 1/2010

Cancer Cell International 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine